Stock listing

Hamburg:ABL Abbott Laboratories Aktie

German listing (Hamburg) of Abbott Laboratories · home listing NYSE:ABT

Follow Abbott Laboratories into a list and get an email when it puts out news.

Share price · HAM:ABL

€94.84 EUR -0.26 (-0.3%)

Close on Nov 20, 2026

Past year -7.3% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€94.54 – €95.08 EURNov 20, 2026
Market cap
€214.4B EURAt the close on Nov 20, 2026 · price × 2.26B shares outstanding
52-week range
€70.02 – €112.04 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€850 EURMedian day 0 shares · 49 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Abbott Laboratories logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:ABT · Home$103.00 USD-1.48 (-1.4%)7,292,834$104.32$105.50$102.80$104.48Close on Nov 20, 2026
Xetra:ABL€94.94 EUR-0.62 (-0.6%)801€95.02€95.90€94.48€95.56Close on Nov 20, 2026
BMV:ABT$1,984.87 MXN-5.13 (-0.3%)26$1,975.00$1,984.87$1,975.00$1,990.00Close on Nov 19, 2026
B3:ABTT3451.40 BRL+0.79 (+1.6%)10551.4051.4051.4050.61Close on Nov 19, 2026
Cboe Canada:ABT$17.93 CAD-0.25 (-1.4%)800$18.06$18.06$17.93$18.18Close on Nov 20, 2026
Stuttgart:ABL€101.15 EUR-1.80 (-1.7%)567€102.45€104.15€100.35€102.95Close on Nov 5, 2026
Frankfurt:ABL€95.66 EUR+0.32 (+0.3%)113€94.80€95.94€94.80€95.34Close on Nov 20, 2026
LSE:0Q15$104.06 USD+0.29 (+0.3%)19,611$103.72$105.59$103.16$103.77Close on Nov 20, 2026
Munich:ABL€94.91 EUR-0.09 (-0.1%)—€94.91€94.91€94.91€95.00Close on Nov 20, 2026
Hamburg:ABL€94.84 EUR-0.26 (-0.3%)—€94.58€95.08€94.54€95.10Close on Nov 20, 2026
Dusseldorf:ABL€94.36 EUR-0.04 (0.0%)—€94.46€95.24€94.36€94.40Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · HAM:ABL · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€99.66-1.44-1.4%€100.60€100.60€99.660
€101.10-1.00-1.0%€103.00€103.45€101.10150
€102.10+3.74+3.8%€97.14€102.10€97.140
€98.36+1.62+1.7%€98.02€98.36€98.020
€96.74+1.60+1.7%€94.82€96.74€94.620
€95.14+2.14+2.3%€94.00€95.14€93.660
€93.00+0.56+0.6%€92.68€93.00€92.660
€92.44-0.12-0.1%€92.28€92.44€91.820
€92.56-0.96-1.0%€93.88€93.88€92.560
€93.52+1.76+1.9%€92.34€93.52€91.880
€91.76+1.54+1.7%€91.10€91.76€91.020
€90.22+2.56+2.9%€88.98€90.22€88.860
€87.66-4.22-4.6%€90.84€91.30€87.660
€91.88-0.56-0.6%€92.46€92.76€91.880
€92.44-0.64-0.7%€93.08€93.08€92.440
€93.08-0.28-0.3%€92.98€93.08€92.980
€93.36+1.68+1.8%€91.62€93.36€91.620
€91.68+0.58+0.6%€91.36€91.68€91.360
€91.10+0.66+0.7%€91.18€91.52€91.100
€90.44+1.72+1.9%€88.74€90.44€88.7420
€88.72+1.90+2.2%€87.50€88.72€87.200
€86.82-0.50-0.6%€87.84€88.12€86.820
€87.32-0.68-0.8%€87.38€87.38€87.320
€88.00-1.02-1.1%€89.16€89.24€88.000
€89.02+3.26+3.8%€86.72€89.02€86.520
€85.76-0.68-0.8%€85.60€86.08€85.600
€86.44-1.66-1.9%€86.96€86.96€86.440
€88.10+0.32+0.4%€89.02€89.02€87.6825
€87.78-0.80-0.9%€88.60€88.62€87.780
€88.58-0.58-0.7%€88.78€89.12€88.580
€89.16-0.80-0.9%€88.46€89.16€88.200
€89.96-1.30-1.4%€90.54€90.88€89.960
€91.26+0.040.0%€90.76€91.26€90.760
€91.22+1.72+1.9%€89.58€91.22€89.560
€89.50-0.14-0.2%€89.34€89.50€89.160
€89.64+1.90+2.2%€88.86€89.64€88.800
€87.74-1.46-1.6%€89.18€89.18€87.740
€89.20+1.18+1.3%€88.18€89.20€87.860
€88.02-1.32-1.5%€89.02€89.02€88.020
€89.34+1.90+2.2%€88.26€89.34€88.260
€87.44-2.24-2.5%€89.04€89.08€87.440
€89.68-1.78-1.9%€90.46€90.46€89.680
€91.46+0.56+0.6%€90.62€91.46€90.620
€90.90-0.12-0.1%€91.32€92.28€90.900
€91.02-3.42-3.6%€92.84€92.84€91.020
€94.44+0.90+1.0%€93.28€94.44€93.180
€93.54-2.94-3.0%€95.26€95.26€93.540
€96.48+1.86+2.0%€93.74€96.48€93.7428
€94.62-0.28-0.3%€94.82€94.86€94.620
€94.90-1.74-1.8%€96.50€96.54€94.6240
€96.64+0.50+0.5%€96.12€96.64€95.821
€96.14-2.24-2.3%€97.68€97.68€96.10200
€98.38-0.34-0.3%€99.28€99.28€98.380
€98.72-1.18-1.2%€99.86€99.86€98.720
€99.90+0.60+0.6%€99.58€99.90€99.580
€99.30+0.96+1.0%€97.44€99.38€97.3035
€98.34-0.20-0.2%€97.74€98.34€97.100
Ticker
Hamburg:ABL
Asset type
Stock
Exchange
Hamburg
Currency
EUR

What changed lately

Latest news

All Abbott Laboratories news

Abbott Laboratories on 6ix

News releases
83 in the last 12 months · 108 in all · newest Nov 19, 2026 · oldest 2025
Calls
32 calls with a replay · 32 with a transcript · latest Oct 21, 2026
Decks
34 decks · latest Nov 20, 2025

Where Abbott Laboratories is listed

ListingExchangeCountryCurrency
NYSE:ABT · Home listingNYSEUnited StatesUSD
gettex:ABLgettexGermanyEUR
BCBA:ABTBCBAArgentinaARS
Xetra:ABLXetraGermanyEUR
TSX:ABTTSXCanadaCAD
Tradegate:ABLTradegateGermanyEUR
BCBA:ABTDBCBAArgentinaUSD
BMV:ABTBMVMexicoMXN
LS Exchange:850103LS ExchangeGermanyEUR
B3:ABTT34B3BrazilBRL
Cboe Canada:ABTCboe CanadaCanadaCAD
Stuttgart:ABLStuttgartGermanyEUR
BCBA:ABTCBCBAArgentinaUSD
Frankfurt:ABLFrankfurtGermanyEUR
LSE:0Q15LSEUnited KingdomUSD
Milan:1ABTMilanItalyEUR
Lang & Schwarz:850103Lang & SchwarzGermanyEUR
SIX Swiss:ABTSIX SwissSwitzerlandCHF
BOATS:ABTBOATSUnited StatesUSD
VIE:ABTViennaAustriaEUR
BCS:ABTCLBCSChileCLP
BCS:ABTBCSChileUSD
Turquoise:ABTNTurquoiseUnited KingdomUSD
Munich:ABLMunichGermanyEUR
Aquis:ABLDAquisUnited KingdomEUR
Hamburg:ABL · This pageHamburgGermanyEUR
Hanover:ABLHanoverGermanyEUR
BSESOF:ABLBSESOFBulgariaEUR
BX Swiss:ABLBX SwissSwitzerlandCHF
BCBA:ABTBBCBAArgentinaARS
Dusseldorf:ABLDusseldorfGermanyEUR
BIVA:ABTBIVAMexicoMXN
BCBA:ABTDBBCBAArgentinaUSD
BVL:ABTUSBVLPeruPEN
BCBA:ABTCBBCBAArgentinaUSD
Aquis:ABLDAquisUnited KingdomEUR
Frankfurt:ABL0FrankfurtGermanyEUR
BCBA:ABT.CIBCBAArgentinaARS

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$205.3B USD
P/E
38.0×
EV/sales
4.3×
EV/EBITDA
25.0×
Price/book
3.5×
Gross margin
56.9%
Operating margin
13.8%
Net margin
9.8%
Debt to equity
0.6×
Beta vs S&P 500
0.11

Forecasts

18 strong buy · 5 buy · 5 hold · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
118.91 USD · Analysts' mean
EPS, year to Dec 2026
5.52 · 27 analysts
Revenue, year to Dec 2026
49.95B · 25 analysts

Team and board

OfficerRole
Rahul SinghAVP

Events

Calls

CallWhenStatus
Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings CallWed, Oct 21, 2026 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2026 Earnings CallThu, Jul 16, 2026 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings CallThu, Apr 16, 2026 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings CallThu, Jan 22, 2026 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings CallWed, Oct 15, 2025 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2025 Earnings CallThu, Jul 17, 2025 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings CallWed, Apr 16, 2025 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2024 Earnings CallWed, Jan 22, 2025 · 9:30 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2024 Earnings CallWed, Oct 16, 2024 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2024 Earnings CallThu, Jul 18, 2024 · 9:00 AM ETReplay
All 32 calls
CallWhenStatus
Abbott Laboratories (NYSE:ABT) Q1 2024 Earnings CallWed, Apr 17, 2024 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2023 Earnings CallWed, Jan 24, 2024 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2023 Earnings CallWed, Oct 18, 2023 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2023 Earnings CallThu, Jul 20, 2023 · 9:30 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2023 Earnings CallWed, Apr 19, 2023 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2022 Earnings CallWed, Jan 25, 2023 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2022 Earnings CallWed, Oct 19, 2022 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2022 Earnings CallWed, Jul 20, 2022 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2022 Earnings CallWed, Apr 20, 2022 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2021 Earnings CallWed, Jan 26, 2022 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2021 Earnings CallWed, Oct 20, 2021 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2021 Earnings CallThu, Jul 22, 2021 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2021 Earnings CallTue, Feb 09, 2021 · 8:30 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2020 Earnings CallWed, Jan 27, 2021 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2020 Earnings CallWed, Oct 21, 2020 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2020 Earnings CallThu, Jul 16, 2020 · 9:30 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2020 Earnings CallThu, Apr 16, 2020 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2019 Earnings CallWed, Jan 22, 2020 · 9:30 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q3 2019 Earnings CallWed, Oct 16, 2019 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q2 2019 Earnings CallWed, Jul 17, 2019 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q1 2019 Earnings CallWed, Apr 17, 2019 · 9:00 AM ETReplay
Abbott Laboratories (NYSE:ABT) Q4 2018 Earnings CallWed, Jan 23, 2019 · 9:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 21, 2026 · Before open−1.9%
Q2 2026Jul 16, 2026 · Before open+10.7%
Q1 2026Apr 16, 2026 · Before open−6.0%
Q4 2025Jan 22, 2026 · Before open−10.0%
Q3 2025Oct 15, 2025 · Before open−2.9%
Q2 2025Jul 17, 2025 · Before open−8.5%
Q1 2025Apr 16, 2025 · Before open+2.8%
Q4 2024Jan 22, 2025 · Before open+0.8%
Q3 2024Oct 16, 2024 · Before open+1.5%
Q2 2024Jul 18, 2024 · Before open−4.4%
All 20 quarters
QuarterResultsShare move
Q1 2024Apr 17, 2024 · Before open−3.0%
Q4 2023Jan 24, 2024 · Before open−2.8%
Q3 2023Oct 18, 2023 · Before open+3.7%
Q2 2023Jul 20, 2023 · Before open+4.2%
Q1 2023Apr 19, 2023 · Before open+7.8%
Q4 2022Jan 25, 2023 · Before open−1.4%
Q3 2022Oct 19, 2022 · Before open−6.5%
Q2 2022Jul 20, 2022 · Before open−1.6%
Q1 2022Apr 20, 2022 · Before open+2.2%
Q4 2021Jan 26, 2022 · Before open−2.6%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (November 2025)Merger or acquisition13 slidesNov 20, 2025
Technical Presentation (October 2025)Technical16 slidesOct 26, 2025
Investor Presentation (October 2024)Investor deck41 slidesOctober 2024
Conference Presentation (October 2024)Conference24 slidesOctober 2024
Technical Presentation (November 2023)Technical8 slidesNovember 2023
Fact Sheet (October 2023)Fact sheet1 slideOct 11, 2023
Investor Presentation (May 2022)Investor deck30 slidesMay 2022
Technical Presentation (April 2022)Technical24 slidesApril 2022
a:care Congress (November 2021)Conference40 slidesNovember 2021
Technical Presentation (October 2021)Technical21 slidesOctober 2021
All 34 decks
DeckKindSlidesDate
A:CARE Congress (October 2021)Conference39 slidesOctober 2021
Technical Presentation (October 2021)Technical45 slidesOctober 2021
Technical Presentation (October 2021)Technical25 slidesOctober 2021
Investor Presentation (October 2021)Investor deck60 slidesOctober 2021
Technical Presentation (October 2021)Technical40 slidesOctober 2021
Technical Presentation (October 2021)Technical25 slidesOctober 2021
Technical Presentation (October 2021)Technical22 slidesOctober 2021
Technical Presentation (October 2021)Technical17 slidesOctober 2021
Q3 2020 Earnings PresentationEarnings19 slidesDec 22, 2020
Abbott — Fact Sheet (September 2020)Fact sheet1 slideSeptember 2020
Fact Sheet (September 2020)Fact sheet1 slideSeptember 2020
Fact Sheet (September 2020)Fact sheet1 slideSeptember 2020
Fact Sheet (August 2020)Fact sheet1 slideAug 28, 2020
Technical Presentation (August 2020)Technical37 slidesAugust 2020
Fact Sheet (2020)Fact sheet1 slideJun 16, 2020
Q3 2019 Earnings PresentationEarnings20 slidesNov 26, 2019
The Clara Abbott Foundation — Investor Presentation (September 2019)Investor deck14 slidesSeptember 2019
Clara Abbott Foundation — Investor Presentation (September 2019)Investor deck18 slidesSeptember 2019
Investor Presentation (May 2017)Investor deck8 slidesMay 2017
Clara Abbott Foundation — Aperçu Présentation8 slidesMay 2017
Clara Abbott Foundation — Investor Presentation (May 2017)Investor deck8 slidesMay 2017
Clara Abbott Foundation — Investor Presentation (March 2016)Investor deck8 slidesMarch 2016
Merger or Acquisition (May 2014)Merger or acquisition4 slidesMay 2014
Abbott — Fact SheetFact sheet1 slide

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue44.3B42.0B40.1B43.7B43.1B34.6B31.9B30.6B27.4B20.9B
Cost of revenue19.3B18.7B18.0B19.1B18.5B15.0B13.2B12.7B12.4B9.09B
Gross profit25.0B23.2B22.1B24.5B24.5B19.6B18.7B17.9B15.0B11.8B
Research and development2.94B2.84B2.74B2.89B2.74B2.42B2.44B2.30B2.26B1.45B
Selling, general and administrative12.3B11.7B10.9B11.2B11.3B9.70B9.77B9.74B9.18B6.74B
Operating income8.05B6.83B6.48B8.36B8.43B5.36B4.53B3.65B1.56B3.03B
Depreciation and amortization1.43B1.34B1.28B1.25B1.49B1.20B1.08B1.10B1.05B803.0M
EBITDA9.49B8.16B7.75B9.62B9.92B6.55B5.61B4.75B2.61B3.83B
Interest expense493.0M559.0M637.0M558.0M533.0M546.0M670.0M826.0M904.0M431.0M
Income before tax8.47B7.01B6.66B8.31B8.21B4.97B4.08B2.87B2.23B1.41B
Income tax1.94B-6.39B941.0M1.37B1.14B497.0M390.0M539.0M1.88B350.0M
Net income6.52B13.4B5.72B6.93B7.07B4.50B3.69B2.37B477.0M1.40B
Earnings per share, basic3.737.673.283.943.972.522.071.340.270.94
Earnings per share, diluted3.727.643.263.913.942.502.061.330.270.94

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents8.52B7.62B6.90B9.88B9.80B6.84B3.86B3.84B9.41B18.6B
Short-term investments417.0M351.0M383.0M288.0M450.0M310.0M280.0M242.0M203.0M155.0M
Receivables7.93B6.92B6.57B6.22B6.49B6.41B5.42B5.18B5.25B3.25B
Inventory6.49B6.19B6.57B6.17B5.16B5.01B4.32B3.80B3.60B2.43B
Current assets26.0B23.7B22.7B25.2B24.2B20.4B15.7B14.6B20.1B26.8B
Property, plant and equipment11.8B10.7B10.2B9.16B8.96B9.03B8.04B7.56B7.61B5.71B
Goodwill24.0B23.1B23.7B22.8B23.2B23.7B23.2B23.3B24.0B7.68B
Total assets86.7B81.4B73.2B74.4B75.2B72.5B67.9B67.2B76.3B52.7B
Current liabilities16.5B14.2B13.8B15.5B13.1B11.9B10.9B9.01B8.91B6.66B
Long-term debt9.90B12.6B13.6B14.5B17.3B18.5B16.7B19.4B27.2B20.7B
Total debt12.9B14.1B14.7B16.8B18.1B18.7B18.1B19.6B27.9B22.0B
Shareholders' equity52.1B47.7B38.6B36.7B35.8B32.8B31.1B30.5B30.9B20.5B
Shares outstanding1.73B1.74B1.74B1.73B1.74B1.74B1.76B1.77B1.76B1.76B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations9.57B8.56B7.26B9.58B10.5B7.90B6.14B6.30B5.57B3.20B
Capital spending-2.17B-2.21B-2.20B-1.78B-1.89B-2.18B-1.64B-1.39B-1.14B-1.12B
Free cash flow7.39B6.35B5.06B7.80B8.65B5.72B4.50B4.91B4.43B2.08B
Cash from investing-2.42B-2.34B-3.13B-1.74B-2.01B-2.21B-1.81B-1.36B-9.62B-248.0M
Cash from financing-6.31B-5.40B-7.09B-7.64B-5.49B-2.78B-4.29B-10.4B-5.28B11.1B
Dividends paid-4.12B-3.84B-3.56B-3.31B-3.20B-2.56B-2.27B-1.97B-1.85B-1.54B
Share buybacks-893.0M-1.29B-1.23B-3.79B-2.30B-403.0M-718.0M-238.0M-117.0M-522.0M
Change in cash906.0M720.0M-2.99B83.0M2.96B2.98B16.0M-5.56B-9.21B13.6B

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 13, 2026Management or board changeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportOct 21, 2026Current reportSEC
8-K · Current reportOct 21, 2026ResultsSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipOct 2, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 2, 2026Insider tradeSEC
4 · Change in ownershipSep 25, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
144 · Notice of proposed saleSep 2, 2026Other filingsSEC
4 · Change in ownershipAug 27, 2026Insider tradeSEC
144 · Notice of proposed saleAug 25, 2026Other filingsSEC
8-K · Current reportAug 20, 2026Current reportSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
10-Q · Quarterly reportJul 28, 2026Quarterly reportSEC
8-K · Current reportJul 16, 2026ResultsSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
4 · Change in ownershipJun 18, 2026Insider tradeSEC
11-K · Annual report of an employee planJun 18, 2026Annual reportSEC
SD · Specialized disclosureMay 27, 2026ESG reportSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 29, 2026Big-stake noticeSEC
10-Q · Quarterly reportApr 29, 2026Quarterly reportSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
4 · Change in ownershipApr 28, 2026Insider tradeSEC
144 · Notice of proposed saleApr 27, 2026Other filingsSEC
4 · Change in ownershipApr 27, 2026Insider tradeSEC
8-K · Current reportApr 27, 2026Management or board changeSEC
S-8 · Registration statement for employee plansApr 24, 2026Offer documentSEC
8-K · Current reportApr 17, 2026Current reportSEC
8-K · Current reportApr 16, 2026ResultsSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 25, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 23, 2026Offer documentSEC
8-K · Current reportMar 23, 2026Current reportSEC
ARS · Annual report to shareholdersMar 13, 2026Annual reportSEC
DEFA14A · Additional proxy materialMar 13, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 13, 2026Meeting noticeSEC
8-K · Current reportMar 9, 2026Material contractSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
8-K · Current reportFeb 26, 2026Material contractSEC
424B5 · ProspectusFeb 25, 2026Offer documentSEC
FWP · Free writing prospectusFeb 23, 2026Offer documentSEC
424B3 · ProspectusFeb 23, 2026Offer documentSEC
S-3ASR · Registration statementFeb 23, 2026Offer documentSEC
8-K · Current reportFeb 20, 2026Current reportSEC
10-K · Annual reportFeb 20, 2026Annual reportSEC
4 · Change in ownershipFeb 6, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
8-K · Current reportJan 22, 2026ResultsSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
3 · Initial statement of ownershipDec 23, 2025Insider tradeSEC
3 · Initial statement of ownershipDec 19, 2025Insider tradeSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
8-K · Current reportDec 12, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedDec 3, 2025Big-stake noticeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
8-K · Current reportNov 21, 2025Current reportSEC
8-K · Current reportNov 20, 2025Material contractSEC
10-Q · Quarterly reportOct 29, 2025Quarterly reportSEC
8-K · Current reportOct 15, 2025ResultsSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
10-Q · Quarterly reportJul 30, 2025Quarterly reportSEC
8-K · Current reportJul 17, 2025ResultsSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 1, 2025Insider tradeSEC
11-K · Annual report of an employee planJun 20, 2025Annual reportSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
8-K · Current reportMay 1, 2025Management or board changeSEC
144 · Notice of proposed saleApr 30, 2025Other filingsSEC
10-Q · Quarterly reportApr 30, 2025Quarterly reportSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
8-K · Current reportApr 28, 2025Meeting outcomeSEC
8-K · Current reportApr 16, 2025ResultsSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
ARS · Annual report to shareholdersMar 14, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 14, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 14, 2025Meeting noticeSEC
4 · Change in ownershipMar 7, 2025Insider tradeSEC
144 · Notice of proposed saleMar 7, 2025Other filingsSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
3 · Initial statement of ownershipMar 3, 2025Insider tradeSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
4 · Change in ownershipFeb 27, 2025Insider tradeSEC
10-K · Annual reportFeb 21, 2025Annual reportSEC
4 · Change in ownershipFeb 7, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 5, 2025Other filingsSEC
4 · Change in ownershipJan 31, 2025Insider tradeSEC
4 · Change in ownershipJan 31, 2025Insider tradeSEC
4 · Change in ownershipJan 30, 2025Insider tradeSEC
144 · Notice of proposed saleJan 30, 2025Other filingsSEC
144 · Notice of proposed saleJan 30, 2025Other filingsSEC
144 · Notice of proposed saleJan 29, 2025Other filingsSEC

This page holds 200 of 1,002 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Abbott Laboratories’ releases · as of Sep 30, 2026

Common shares
1,731,941,601
Fully diluted
1,731,941,601

Fully diluted

LineSharesAs of
Common shares1,731,941,601Sep 30, 2026

Share count over time

CountShares
Sep 30, 20261,731,941,601

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard180M10.4%US$17.8BSep 30, 2026
BlackRock152M8.8%US$15BSep 30, 2026
State Street81.4M4.7%US$8.05BSep 30, 2026
Capital Group80.7M4.7%US$7.98BSep 30, 2026
Schwab57.2M3.3%US$5.65BSep 30, 2026
Geode Capital39.6M2.3%US$3.89BSep 30, 2026
JPMorgan29.7M1.7%US$3BSep 30, 2026
Morgan Stanley28.9M1.7%US$2.86BSep 30, 2026
T. Rowe Price27.7M1.6%US$2.73BSep 30, 2026
Franklin Templeton20.5M1.2%US$2.37BSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Bank of America18.6M1.1%US$1.84BSep 30, 2026
Northern Trust18M1.0%US$1.78BSep 30, 2026
DWS17.7M1.0%US$1.75BSep 30, 2026
Sun Life14.9M0.86%US$1.48BSep 30, 2026
Fidelity14.6M0.84%US$1.45BSep 30, 2026
State Farm Mutual Automobile Insurance Co13.6M0.78%US$1.34BSep 30, 2026
Arrowstreet Capital, Limited Partnership13.5M0.78%US$1.33BSep 30, 2026
Goldman Sachs12.8M0.74%US$1.26BSep 30, 2026
Legal & General11.8M0.68%US$1.17BSep 30, 2026
Invesco10.6M0.61%US$1.05BSep 30, 2026
Nuveen10.4M0.60%US$1.03BSep 30, 2026
UBS9.94M0.57%US$983MSep 30, 2026
Wells Fargo9.91M0.57%US$980MSep 30, 2026
BNY9.85M0.57%US$973MSep 30, 2026
Amundi9.15M0.53%US$904MSep 30, 2026
Flossbach Von Storch SE9.03M0.52%US$893MSep 30, 2026
RBC9.01M0.52%US$891MSep 30, 2026
Grantham, Mayo, Van Otterloo & Co. LLC8.97M0.52%US$886MSep 30, 2026
Dimensional8.66M0.50%US$856MSep 30, 2026
Ameriprise8.63M0.50%US$853MSep 30, 2026
Janus Henderson7.55M0.44%US$746MSep 30, 2026
AQR Capital Management LLC7.24M0.42%US$716MSep 30, 2026
MUFG5.59M0.32%US$552MSep 30, 2026
Scotiabank5.35M0.31%US$528MSep 30, 2026
Assenagon Asset Management S.A.5.19M0.30%US$513MSep 30, 2026
Barrow Hanley Mewhinney & Strauss LLC5.08M0.29%US$502MSep 30, 2026
Two Sigma5.02M0.29%US$496MSep 30, 2026
Raymond James Financial Inc4.91M0.28%US$486MSep 30, 2026
Manufacturers Life Insurance Company, The4.79M0.28%US$474MSep 30, 2026
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main4.79M0.28%US$473MSep 30, 2026
Swiss National Bank4.76M0.28%US$471MSep 30, 2026
Wellington4.65M0.27%US$460MSep 30, 2026
Allianz4.63M0.27%US$458MSep 30, 2026
PNC Financial Services Group, Inc.4.58M0.26%US$453MSep 30, 2026
CIBC4.41M0.25%US$437MSep 30, 2026
National Pension Service4.24M0.24%US$419MSep 30, 2026
AllianceBernstein4.22M0.24%US$417MSep 30, 2026
DekaBank Deutsche Girozentrale4.04M0.23%US$407MSep 30, 2026
Stifel Financial Corp3.8M0.22%US$376MSep 30, 2026
Sumitomo Mitsui Trust Group, Inc.3.7M0.21%US$366MSep 30, 2026

This page holds 50 of 3,007 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund55.3M3.2%US$5.02BJun 30, 2026
Vanguard 500 Index Fund45.1M2.6%US$4.1BJun 30, 2026
Schwab U.S. Dividend Equity ETF32.8M1.9%US$2.81BMay 31, 2026
iShares Core S&P 500 ETF24M1.4%US$2.17BJun 30, 2026
Fidelity 500 Index Fund22.3M1.3%US$1.9BMay 31, 2026
Washington Mutual Investors Fund17.5M1.0%US$1.85BJul 31, 2026
Vanguard Value Index Fund16.6M0.96%US$1.5BJun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF12.3M0.71%US$1.12BJun 30, 2026
Investment Co of America10.3M0.60%US$937MJun 30, 2026
Vanguard Dividend Appreciation Index Fund9.86M0.57%US$1.04BJul 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard Institutional Index Fund9.46M0.55%US$858MJun 30, 2026
American Mutual Fund8.09M0.47%US$855MJul 31, 2026
Vanguard High Dividend Yield Index Fund6.98M0.40%US$738MJul 31, 2026
Capital Income Builder6.77M0.39%US$715MJul 31, 2026
MFS Value Fund6.62M0.38%US$567MMay 31, 2026
iShares U.S. Medical Devices ETF5.64M0.33%US$512MJun 30, 2026
Columbia Dividend Income Fund5.59M0.32%US$478MMay 31, 2026
Capital World Growth & Income Fund5.57M0.32%US$477MMay 31, 2026
Vanguard Health Care Index Fund5.22M0.30%US$447MMay 31, 2026
T. Rowe Price Value Fund, Inc.5.08M0.29%US$461MJun 30, 2026
Franklin Rising Dividends Fund4.96M0.29%US$451MJun 30, 2026
JPMorgan Equity Income Fund4.56M0.26%US$414MJun 30, 2026
iShares Core Dividend Growth ETF4.46M0.26%US$471MJul 31, 2026
American Funds Fundamental Investors4.23M0.24%US$384MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF4.15M0.24%US$377MJun 30, 2026
Schwab S&P 500 Index Fund3.89M0.22%US$411MJul 31, 2026
iShares Russell 1000 Value ETF3.87M0.22%US$351MJun 30, 2026
Vanguard Health Care Fund3.72M0.21%US$393MJul 31, 2026
Growth Fund of America3.39M0.20%US$290MMay 31, 2026
Fidelity Total Market Index Fund3.29M0.19%US$281MMay 31, 2026
iShares Core High Dividend ETF3.24M0.19%US$342MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account3.19M0.18%US$289MJun 30, 2026
Capital Group Dividend Value ETF3.1M0.18%US$265MMay 31, 2026
Vanguard Equity Income Fund2.93M0.17%US$266MJun 30, 2026
iShares S&P 500 Value ETF2.86M0.17%US$259MJun 30, 2026
Fidelity Series Total Market Index Fund2.65M0.15%US$227MMay 31, 2026
GMO Quality Fund2.62M0.15%US$224MMay 31, 2026
T. Rowe Price Health Sciences Fund, Inc.2.48M0.14%US$225MJun 30, 2026
MFS Growth Fund2.39M0.14%US$205MMay 31, 2026
State Street(R) SPDR(R) S&P(R) Dividend ETF2.35M0.14%US$214MJun 30, 2026
New Perspective Fund2.29M0.13%US$208MJun 30, 2026
iShares Core S&P Total U.S. Stock Market ETF2.24M0.13%US$203MJun 30, 2026
State Street(R) SPDR(R) Portfolio S&P 500(R) Value ETF2.12M0.12%US$192MJun 30, 2026
Invesco S&P 500 Equal Weight ETF2.09M0.12%US$221MJul 31, 2026
Franklin Mutual Global Discovery Fund2.04M0.12%US$185MJun 30, 2026
Janus Henderson Balanced Fund2.04M0.12%US$185MJun 30, 2026
Vanguard Large-Cap Index Fund2.03M0.12%US$185MJun 30, 2026
Franklin Income Fund2M0.12%US$181MJun 30, 2026
Schwab U.S. Large-Cap ETF1.85M0.11%US$158MMay 31, 2026
Growth-Income Fund1.8M0.10%US$163MJun 30, 2026

This page holds 50 of 955 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Moreland Mary K
Officer: EXECUTIVE VICE PRESIDENT
Sale3,500USD 116.00US$406KNov 5, 2026
McCoy John A. Jr.
Officer: VICE PRESIDENT AND CONTROLLER
Sale27USD 109.54US$2,958Sep 2, 2026
Ford Robert B
Director, Officer: CHAIRMAN AND CEO
Sale218,535USD 115.57US$25.3MAug 25, 2026
Ford Robert B
Director, Officer: CHAIRMAN AND CEO
Sale180,297USD 116.19US$20.9MAug 25, 2026
Morrone Louis H.
Officer: EXECUTIVE VICE PRESIDENT
Sale5,850USD 109.83US$643KAug 11, 2026
Stratton John G
Director
Buy2,000USD 86.82US$174KMay 7, 2026
Starks Daniel J
Director
Buy10,000USD 92.65US$927KApr 27, 2026
Boudreau Philip P
Officer: EVP AND CFO
Buy2,200USD 91.50US$201KApr 23, 2026

Big stakes

StakeStakeSharesDateFiling
Vanguard Capital Management LLC7.50%131MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Edward M Liddy
Other companies: AbbVie Inc. (Director · Dec 12, 2012 – Mar 31, 2022 · Past); American International Group, Inc. New (Chairman & CEO, Director · Sep 18, 2008 – Sep 18, 2008 · Past); Boeing Company (the) (Director · Aug 28, 2007 – Apr 1, 2020 · Past); Goldman Sachs Group, Inc. (the) (Director · Dec 15, 2006 – Dec 19, 2007 · Past); Allstate Corporation (the) (Chairman, Director · Feb 21, 2006 – Feb 22, 2008 · Past); 3M Company (Director · Dec 31, 2005 – May 1, 2020 · Past); Kroger Company (the) (Director · Dec 31, 2005 – Dec 31, 2005 · Past)
Director · Jun 11, 2010 – Apr 24, 2020 · Past
Jack M Greenberg
Other companies: IQVIA Holdings, Inc. (Director · May 8, 2013 – Apr 26, 2018 · Past); Western Union Company (the) (Director · Sep 29, 2009 – Feb 20, 2015 · Past); InnerWorkings Inc (Director · Aug 15, 2006 – Oct 1, 2020 · Past); Allstate Corporation (the) (Director · Feb 23, 2006 – Mar 5, 2015 · Past); First Data Corporation (Director · Feb 8, 2006 – Sep 1, 2006 · Past); Hasbro, Inc. (Director · Dec 30, 2005 – Mar 31, 2015 · Past); ManpowerGroup (Director · Dec 30, 2005 – Jan 1, 2014 · Past)
Director · Apr 28, 2006 – Apr 28, 2006 · Past
Glenn F Tilton
Other companies: Phillips 66 (Director · Since at least May 1, 2012); AbbVie Inc. (Director · Dec 12, 2012 – May 9, 2025 · Past); Corning Incorporated (Director · Nov 30, 2010 – Feb 1, 2012 · Past); United Airlines Holdings, Inc. (Director · Feb 1, 2006 – Jun 12, 2013 · Past); Txu Corp (Director · Jan 9, 2006 – Jan 9, 2007 · Past); Lincoln National Corporation (Director · Dec 30, 2005 – Mar 31, 2007 · Past)
Director · Apr 27, 2007 – Apr 29, 2022 · Past
Kevin T Conroy
Other companies: American Exceptionalism Acquisition Corp. A (Director · Since at least Sep 25, 2025); Align Technology, Inc. (Director · Since at least Dec 5, 2023); EXACT Sciences Corporation (President and CEO, Director · Since at least Mar 18, 2009); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Mar 6, 2023 · Past); ARYA Sciences Acquisition Corp (Director · Oct 5, 2018 – Jul 1, 2020 · Past); Epizyme Inc (Director · Feb 6, 2017 – Aug 12, 2022 · Past)
Director · Since at least Apr 24, 2026
Roxanne Austin
Other companies: Freshworks Inc. (Director · Since at least Sep 21, 2021); Verizon Communications Inc. (Director · Since at least Oct 2, 2020); CrowdStrike Holdings, Inc. (President, Austin Investment Advisors · Since at least Jun 11, 2019); AbbVie Inc. (President · Since at least Dec 12, 2012); Teledyne Technologies Incorporated (Director · Jan 29, 2006 – Jun 5, 2020 · Past); Target Corporation (Director · Jan 11, 2006 – Jun 2, 2020 · Past)
Director · Apr 28, 2006 – Apr 23, 2021 · Past
W James Farrell
Other companies: 3M Company (Director · Aug 14, 2006 – May 13, 2014 · Past); Allstate Corporation (the) (Director · Jun 1, 2006 – Dec 7, 2012 · Past); United Airlines Holdings, Inc. (Director · Feb 1, 2006 – Jun 9, 2012 · Past); Illinois Tool Works Inc. (Chairman, Director · Jan 5, 2006 – Apr 21, 2006 · Past); Mondelez International, Inc. (Director · Dec 31, 2005 – Apr 26, 2006 · Past)
Director · Jan 16, 2006 – Apr 29, 2016 · Past
William A Osborn
Other companies: General Dynamics Corporation (Director · Dec 1, 2009 – Mar 8, 2021 · Past); Caterpillar, Inc. (Director · Jun 14, 2006 – Mar 1, 2021 · Past); Tribune Media Company (Director · May 3, 2006 – Dec 20, 2007 · Past); Northern Trust Corporation (Chairman of the Board, Director · Jan 20, 2006 – Dec 15, 2008 · Past)
Director · Jan 2, 2008 – Apr 29, 2022 · Past
William G Dempsey
Other companies: Ashland Inc. (Director · Jul 20, 2016 – Dec 30, 2022 · Past); Hill-Rom Holdings Inc (Director · Mar 7, 2014 – Dec 13, 2021 · Past); Hospira Inc (Director · Aug 17, 2011 – Sep 3, 2015 · Past); Landauer Inc (Director · Oct 30, 2008 – Oct 19, 2017 · Past)
Executive Vice President · Dec 31, 2005 – Aug 7, 2007 · Past
Carlos Albán
Other companies: Solventum Corporation (Director · Since at least Apr 1, 2024); SpringWorks Therapeutics Inc (Director · Since at least Jul 14, 2022); AbbVie Inc. (Vice Chairman · Dec 7, 2012 – Nov 16, 2020 · Past)
Senior Vice President · Oct 15, 2009 – Dec 1, 2012 · Past
John G Stratton
Other companies: Frontier Communications Parent Inc (Exec. Chairman of the Board, Director · Since at least Apr 30, 2021); General Dynamics Corporation (Director · Since at least Feb 5, 2020); Verizon Communications Inc. (EVP&Pres - Global Operations · Oct 5, 2017 – May 31, 2018 · Past)
Director · Since at least Sep 30, 2017
All 74 people
PersonSeat
Michael Dale
Other companies: CVRx, Inc. (Chief Executive Officer and President · Since at least Apr 20, 2026); Axogen, Inc. (President, Chief Executive Officer and Board Director · Since at least Aug 9, 2024); Ats Medical Inc (Chief Executive Officer · Jan 10, 2006 – Aug 12, 2010 · Past)
SENIOR VICE PRESIDENT · Nov 11, 2019 – Feb 28, 2023 · Past
Michelle Kumbier
Other companies: Ryerson Holding Corporation (Director · Since at least Apr 25, 2024); Teledyne Technologies Incorporated (Director · Since at least Oct 20, 2020); Tenneco Inc (Director · Aug 10, 2021 – Nov 17, 2022 · Past)
Director · Since at least Feb 23, 2021
Nancy McKinstry
Other companies: Automatic Data Processing, Inc. (Director · Since at least Nov 11, 2026); Mondelez International, Inc. (Director · Since at least May 21, 2025); Accenture plc (Director · Since at least May 15, 2019)
Director · Since at least Apr 26, 2019
Samuel C Scott III
Other companies: GCM Grosvenor Inc. (Director · Since at least Nov 17, 2020); Motorola Solutions, Inc. (Director · May 16, 2016 – May 14, 2018 · Past); The Bank of New York Mellon Corporation (Director · Apr 22, 2016 – Feb 11, 2022 · Past)
Director · Apr 29, 2016 – Apr 26, 2019 · Past
Thomas C. Freyman
Other companies: AbbVie Inc. (Director · Since at least May 8, 2020); Hanger Inc (Director · Nov 14, 2017 – Oct 3, 2022 · Past); Tenneco Inc (Director · Jul 14, 2015 – Nov 17, 2022 · Past)
Executive Vice President · Feb 19, 2016 – Jul 29, 2016 · Past
Thomas F Chen
Other companies: Stericycle Inc (Director · May 21, 2014 – Nov 4, 2024 · Past); Baxter International Inc. (Director · Jan 25, 2013 – May 3, 2022 · Past); Cyanotech Corporation (Director · Jun 6, 2011 – Aug 27, 2012 · Past)
Senior Vice President · Apr 24, 2006 – May 25, 2010 · Past
William D Smithburg
Other companies: Niagen Bioscience, Inc. (Director · Jun 6, 2016 – Jun 6, 2016 · Past); Corning Incorporated (Director · Dec 30, 2005 – Mar 30, 2012 · Past); Northern Trust Corporation (Director · Dec 30, 2005 – Apr 20, 2010 · Past)
Director · Dec 31, 2005 – Nov 9, 2010 · Past
Andrea F. Wainer
Other companies: Neogen Corporation (Director · Since at least May 13, 2025); Analog Devices, Inc. (Director · Since at least Jan 9, 2025)
RETIRED EVP · Jun 3, 2019 – Feb 28, 2025 · Past
Daniel J Starks
Other companies: Urologix (Director · Aug 22, 2006 – Nov 11, 2008 · Past); St. Jude Medical Inc (Director · Feb 7, 2006 – Jan 4, 2017 · Past)
Director · Since at least Feb 16, 2017
Darren W McDew
Other companies: GE Aerospace (Director · Since at least Mar 30, 2023); Parsons Corporation (Director · Since at least Apr 20, 2021)
Director · Since at least Apr 23, 2021
Heather L. Mason
Other companies: Immatics N.V. (Non-Executive Director · Since at least Mar 18, 2026); Assertio Holdings, Inc. (Director · Since at least May 19, 2020)
Executive Vice President · May 1, 2008 – Jul 1, 2017 · Past
James V Mazzo
Other companies: Aerie Pharmaceuticals Inc. (Director · Jun 11, 2014 – Jun 11, 2014 · Past); Microsemi Corporation (Director · Aug 7, 2012 – Feb 11, 2014 · Past)
Senior Vice President · Aug 26, 2010 – Feb 4, 2013 · Past
Lisa D Earnhardt
Other companies: Nevro Corp (Director · May 21, 2018 – May 21, 2018 · Past); Intersect ENT Inc (Director · Oct 16, 2017 – Jul 24, 2019 · Past)
EVP AND GROUP PRESIDENT · Since at least Jun 10, 2019
Michael Roman
Other companies: Waystar Holding Corp. (Director · Since at least Jun 4, 2025); 3M Company (Chairman of the Board, Director · Feb 2, 2016 – Feb 3, 2025 · Past)
Director · Since at least Apr 23, 2021
Rahul Singh
Other companies: Dow Inc. (AVP · Since at least May 15, 2026); 3M Company (AVP · Since at least Apr 27, 2026)
AVP · Since at least May 5, 2026
Robert J Alpern
Other companies: AbbVie Inc. (Director · Since at least Dec 12, 2012); Tricida Inc (Director · Jun 27, 2018 – Nov 23, 2022 · Past)
Director · Since at least Oct 10, 2008
Roy S Roberts
Other companies: AbbVie Inc. (Director · Dec 12, 2012 – May 8, 2015 · Past); Burlington Northern Santa Fe Corp (Director · Dec 30, 2005 – Feb 12, 2010 · Past)
Director · Dec 31, 2005 – Jan 31, 2011 · Past
Charles Brynelsen
Other companies: Envoy Medical, Inc. (Director · Since at least Sep 29, 2023)
SENIOR VICE PRESIDENT · Feb 16, 2018 – Feb 26, 2021 · Past
Edward L Michael
Other companies: QuidelOrtho Corporation (Director · Since at least May 27, 2022)
Executive Vice President · Mar 1, 2007 – Feb 29, 2012 · Past
Holger A Liepmann
Other companies: Verenium Corp (Director · Mar 31, 2013 – Oct 31, 2013 · Past)
Executive Vice President · Jan 31, 2006 – Dec 23, 2010 · Past
Jacob A Orville
Other companies: EXACT Sciences Corporation (EVP, GM, Screening · Since at least Feb 16, 2021)
Senior Vice President · Since at least Mar 23, 2026
Jeffrey R Binder
Other companies: Biomet Inc (President & CEO, Director · Feb 26, 2007 – Feb 26, 2007 · Past)
Senior Vice President · Jan 15, 2006 – Feb 17, 2007 · Past
John A McCoy
Other companies: Baxalta Inc (SVP and Controller · Jun 30, 2015 – Jun 3, 2016 · Past)
VICE PRESIDENT AND CONTROLLER · Since at least Sep 1, 2023
Michael O'Grady
Other companies: Northern Trust Corporation (Chairman and CEO, Director · Since at least Dec 3, 2025)
Director · Since at least Apr 25, 2025
Michael T Rousseau
Other companies: St. Jude Medical Inc (Director, President and CEO, Director · Feb 3, 2006 – Jan 4, 2017 · Past)
Pres., Cardiovas. & Neuromod. · Jan 4, 2017 – Jul 7, 2017 · Past
Murthy V Simhambhatla
Other companies: Evolus, Inc. Common Stock (See Remarks, Director · Feb 7, 2018 – Feb 7, 2018 · Past)
Senior Vice President · Jan 1, 2013 – Feb 27, 2015 · Past
Richard A Gonzalez
Other companies: AbbVie Inc. (Director · Dec 7, 2012 – Mar 31, 2025 · Past)
Executive Vice President · Nov 17, 2005 – Apr 6, 2012 · Past
Sally E Blount
Other companies: Ulta Beauty, Inc. (Director · Dec 6, 2017 – Jun 2, 2021 · Past)
Director · Since at least Dec 9, 2011
A David ForrestSenior Vice President · Sep 17, 2010 – Sep 17, 2013 · Past
Alejandro D WellischSENIOR VICE PRESIDENT · Oct 1, 2017 – Feb 28, 2023 · Past
Andrew H LaneEXECUTIVE VICE PRESIDENT · Feb 16, 2018 – Nov 15, 2021 · Past
Charles D FoltzSenior Vice President · Apr 1, 2013 – Apr 1, 2015 · Past
Christopher J CalamariSENIOR VICE PRESIDENT · Jul 1, 2021 – Feb 28, 2023 · Past
Christopher J ScogginsEXECUTIVE VICE PRESIDENT · Since at least Apr 1, 2019
Claire Babineaux-FontenotDirector · Since at least Apr 25, 2025
Daniel Gesua Sive SalvadoriEVP AND GROUP PRESIDENT · Since at least Sep 26, 2014
Deepak S NathSenior Vice President · Apr 1, 2015 – Apr 28, 2017 · Past
Elizabeth C CushmanEVP, GC AND SECRETARY · Since at least Jun 27, 2025
Eric ShroffSenior Vice President · Since at least Mar 1, 2025
Fernando MateusSENIOR VICE PRESIDENT · Dec 1, 2021 – Feb 28, 2023 · Past
Georges H DeVosSenior Vice President · Jul 1, 2013 – Feb 27, 2015 · Past
Hubert L AllenEXECUTIVE VICE PRESIDENT, GC · Feb 1, 2021 – Feb 28, 2025 · Past
Jaime ContrerasSenior Vice President · Sep 16, 2013 – Apr 21, 2020 · Past
Jared WatkinSENIOR VICE PRESIDENT · Jun 15, 2015 – Feb 28, 2023 · Past
Jean-Yves PaveeSenior Vice President · Jul 1, 2013 – Jul 1, 2016 · Past
John F GinascolEXECUTIVE VICE PRESIDENT · Jun 3, 2019 – Feb 28, 2023 · Past
John M CapekEXECUTIVE VICE PRESIDENT · Feb 17, 2023 – Feb 28, 2023 · Past
Joseph J ManningEXECUTIVE VICE PRESIDENT · Jan 16, 2017 – Feb 28, 2023 · Past
Julie L TylerSENIOR VICE PRESIDENT · Jul 1, 2021 – Feb 28, 2023 · Past
Louis H MorroneEXECUTIVE VICE PRESIDENT · Since at least Jul 1, 2021
Mary K MorelandEXECUTIVE VICE PRESIDENT · Since at least Feb 16, 2021
Michael J PedersonSENIOR VICE PRESIDENT · Jul 21, 2017 – Feb 28, 2023 · Past
Michael J WarmuthExecutive Vice President · Dec 15, 2008 – Feb 28, 2017 · Past
Nita AhujaDirector · Since at least Dec 12, 2025
Patricia Paola GonzalezDirector · Since at least Aug 30, 2021
Paul K MagillSenior Vice President · Nov 1, 2012 – Feb 15, 2013 · Past
Philip P BoudreauEVP AND CFO · Since at least Aug 8, 2025
Randel William WoodgriftSENIOR VICE PRESIDENT · Apr 1, 2019 – Feb 28, 2023 · Past
Robert B FordCHAIRMAN AND CEO, Director · Since at least Jun 6, 2019
Robert E Funck JrEXECUTIVE VICE PRESIDENT · Mar 1, 2013 – May 10, 2024 · Past
Roger BirdSENIOR VICE PRESIDENT · Mar 1, 2015 – Apr 27, 2021 · Past
Sean ShrimptonSenior Vice President · May 15, 2017 – Dec 31, 2018 · Past
Sharon J BrackenSenior Vice President · Jul 10, 2017 – Mar 31, 2019 · Past
Stephen R FussellExecutive Vice President · Jan 30, 2018 – Apr 23, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Abbott Laboratories.